Moderna Inc. (NASDAQ:MRNA) saw its share price climb to a new four-year high on Thursday, as investors cheered news that it was exploring investment opportunities in the Middle East.
Moderna CEO Stéphane Bancel joins ‘Mornings with Maria’ to discuss the company’s landmark cancer vaccine partnership with Merck. Bancel details the promising Phase 3 melanoma trial results and outlines Moderna’s latest financial growth outlook.
